Recombinant SARS-CoV-2 Spike protein, S1 (RBD aa319-541)
|Catalog No: 81343||Format: 100 µg||$410||Buy|
Request a quote for a bulk order Request Quote
Expressed In: 293 cells Protein Species: Virus
A representative Technical Data Sheet (TDS) is provided here. Please refer to the lot-specific TDS you will receive with your order for the lot-specific buffer contents and protein concentration.
COVID-19, which is short for coronavirus disease 2019, is the official name of the respiratory disease caused by infection with the novel coronavirus SARS-CoV-2. The virus that causes COVID-19 was named SARS-CoV-2 because it is a coronavirus genetically similar to, yet distinct from, the virus that caused the severe acute respiratory syndrome (SARS) outbreak in 2003. Studying the details of how this virus replicates and causes the disease will allow scientists and physicians to more rapidly develop fast and accurate methods of detection as well as to deploy therapeutic and vaccine strategies.
This product was manufactured as described in Protein Details and has been validated for use in ELISA. All available data for the protein is shown.
Recombinant SARS-CoV-2 Spike protein was expressed in 293 cells and contains a C-terminal 6XHis-Tag with an observed molecular weight of 40 kDa. The recombinant protein is >90% pure by SDS-PAGE.
Recombinant proteins in solution are temperature sensitive and must be stored at -80°C to prevent degradation. Avoid repeated freeze/thaw cycles and keep on ice when not in storage.
This product is for research use only and is not for use in diagnostic procedures. This product is guaranteed for 6 months from date of arrival.